Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation?
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 63 (1) , 298-305
- https://doi.org/10.1046/j.1523-1755.2003.00705.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Glucotoxicity of the peritoneal membrane: the case for VEGFNephrology Dialysis Transplantation, 2001
- Reactive carbonyl compounds related uremic toxicity (“carbonyl stress”)Kidney International, 2001
- Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation productsKidney International, 2001
- Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compoundsKidney International, 2000
- Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysisFEBS Letters, 1999
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compoundsNephrology Dialysis Transplantation, 1999
- Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathyProceedings of the National Academy of Sciences, 1997
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Toxicity of Heat Sterilized Peritoneal Dialysis Fluids is Derived from Degradation of GlucoseAsaio Journal, 1992